1. Home
  2. BTBT vs RAPP Comparison

BTBT vs RAPP Comparison

Compare BTBT & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bit Digital Inc.

BTBT

Bit Digital Inc.

HOLD

Current Price

$2.20

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$27.35

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTBT
RAPP
Founded
2015
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
BTBT
RAPP
Price
$2.20
$27.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$6.50
$47.80
AVG Volume (30 Days)
32.2M
340.0K
Earning Date
03-13-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$105,703,143.00
N/A
Revenue This Year
$7.15
N/A
Revenue Next Year
$90.95
N/A
P/E Ratio
$3.35
N/A
Revenue Growth
7.86
N/A
52 Week Low
$1.69
$6.43
52 Week High
$4.55
$42.27

Technical Indicators

Market Signals
Indicator
BTBT
RAPP
Relative Strength Index (RSI) 49.74 48.07
Support Level $2.02 $26.00
Resistance Level $2.37 $28.42
Average True Range (ATR) 0.15 1.69
MACD 0.00 -0.09
Stochastic Oscillator 45.35 34.89

Price Performance

Historical Comparison
BTBT
RAPP

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: